Pharmaceutical ingredients include phosphate at a concentration of 60-99%, which is used to treat cardiovascular diseases, reduce triglyceride levels, reduce LDL cholesterol and increase the accuracy of Hdl cholesterol.

• 收藏
• 分享

专利权人:

ACASTI PHARMA; INC.

发明人:

SAMPALIS, FOTINI,HARLAND, HENRI.

申请号：

CL2012001124

公开号：

CL2012001124A1

申请日:

2012.04.27

申请国别(地区):

CL

年份:

2013

代理人:

摘要：

Therapeutic composition comprising compounds Concentrated phospholipid derived Fatty Acid in a concentration of 45 to 99% p / pUseful for treating or Preventing a disorder Ethical / metabolic syndrome or a neurodegenerative disorder.<；p>；Composició；n fosfolipí；dica terapé；utica concentrada que comprende compuestos derivados de á；cidos grasos, en una concentració；n de 60 ；a 99 % p/p, ú；til para tratar o prevenir un trastorno cardiometabó；lico/sí；ndrome metabó；lico o un trastorno neurodegenerativo.<；/p>；

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/